Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Choosing a total market fund for a Roth IRA doesn't have to be hard. Compare options, fees, and diversification to build a solid retirement strategy.
28,468 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
A high-yield ETF draws retiree interest, but Warren Buffett would never chase yields at the expense of long-term grow...
As rates shift and banks adjust to a new credit environment, PFF remains the dominant preferred-stock ETF with a siza...
As 2026 brings potential changes to Medicare, retirees and investors face questions about access to care and costs. T...
Deciding how to own the S&P 500 can feel overwhelming. This guide breaks down the pros and cons of RSP versus VOO, sh...
When a tech giant faces a costly lawsuit over a celebrity image, it isn’t just a legal story—it’s a personal finance ...
Wasatch Advisors dumped a large Trex stake, triggering a sharp move in Trex shares. This piece explains what happened...
A tech-led rally has spotlighted triple-leveraged ETFs, sparking debate on long-run viability. This piece explains ho...
Institutional investors and hedge funds are quietly shaping the quantum stock landscape. This comprehensive guide bre...
Investors are weighing bloom energy stock: buy options as the company scales its solid oxide fuel cells for AI data c...
A rising wave of data centers and AI workloads is straining power grids. Learn how a strategic nuclear stock could ri...
A fresh AI chip IPO in 2026 could redefine how growth looks in semiconductors. This article breaks down why the stock...